Watch SION. Know when insiders buy.
One email the day a filing lands. Free.
SION
Sionna Therapeutics, Inc.
6.00
+0.04 +0.67%
USD · close Sep 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
36
FLAG · insiders 25, shorts 47
Insiders, 90 days
−$21.8M
net selling · 0 buys, 2 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $271.3MP/E —DIV YIELD —FCF YIELD -28.09%REV TTM —NET INCOME −$97.4MNET CASH —52W 4.50 – 51.04SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$32.5M | −$29.9M | — | -0.66 | −$22.2M | $0 | −$22.2M | Aug 6 |
| Q1 2026 · Mar 31 | — | — | — | −$29.6M | −$26.8M | — | -0.60 | −$21.8M | $0 | −$21.8M | Aug 6 |
| Q4 2025 · Dec 31derived | — | — | — | −$23.6M | −$20.4M | — | -0.45 | −$16.6M | $204K | −$16.8M | Mar 2 |
| Q3 2025 · Sep 30 | — | — | — | −$23.8M | −$20.3M | — | -0.46 | −$15.2M | $87K | −$15.3M | Nov 5 |
| Q2 2025 · Jun 30 | — | — | — | −$21.9M | −$18.1M | — | -0.41 | −$18.2M | $0 | −$18.2M | Aug 6 |
| Q1 2025 · Mar 31 | — | — | — | −$19.7M | −$16.5M | — | -0.62 | −$16.3M | $86K | −$16.4M | Aug 6 |
| Q4 2024 · Dec 31derived | — | — | — | −$18.1M | −$15.8M | — | -3.18 | −$11.8M | $27K | −$11.8M | Mar 2 |
| Q3 2024 · Sep 30 | — | — | — | −$28M | −$25.4M | — | -5.67 | −$17.7M | $0 | −$17.7M | Nov 5 |
| Q2 2024 · Jun 30 | — | — | — | −$11.3M | −$8.6M | — | -2710.00 | −$10.1M | $0 | −$10.1M | Nov 5 |
| Q1 2024 · Mar 31 | — | — | — | −$13.1M | −$11.8M | — | -3840.00 | −$13.2M | $0 | −$13.2M | Nov 5 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$89M | −$75.3M | — | -1.88 | −$66.3M | $377K | −$66.7M | — | — |
| FY2024 · to Dec 31 | — | — | −$70.6M | −$61.7M | — | -15.99 | −$52.8M | $27K | −$52.8M | — | — |
Every number comes from Sionna Therapeutics, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.